Korean J Anesthesiol > Volume 77(2); 2024 > Article |
|
Conflicts of Interest
Klaus Görlinger works as the Medical Director of TEM innovations GmbH/Werfen PBM, Munich, Germany since 2012.
Data Availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
Author Contributions
Jaemoon Lee (Conceptualization; Data curation; Formal analysis; Writing – original draft)
Dong-Kyu Lee (Conceptualization; Data curation; Formal analysis)
Won-Kyoung Kwon (Conceptualization; Data curation; Formal analysis)
Sookyung Lee (Data curation; Formal analysis)
Chung-Sik Oh (Conceptualization; Data curation; Formal analysis)
Klaus Görlinger (Conceptualization; Data curation; Formal analysis)
Tae-Yop Kim (Conceptualization; Data curation; Formal analysis; Funding acquisition; Writing – review & editing)
Values are presented as median (Q1, Q3). Hct: hematocrit, ROTEM: rotational thromboelastometry, UF: ultrafiltration, CPB: cardiopulmonary bypass, CT-EXTEM: clotting time of EXTEM, CFT-EXTEM: clot formation time of EXTEM, MCF-EXTEM: maximum clot firmness of EXTEM, A5-FIBTEM and MCF-FIBTEM: clot amplitude at 5 min after clot initiation and maximum clot firmness in FIBTEM, LI30-EXTEM: lysis index at 30 min of EXTEM, Pre-CPB: after induction, Pre-UF: immediately before applying ultrafiltration, Post-UF: immediately after applying ultrafiltration, Post-CPB: after weaning from CPB and The comparisons of Pre-UF vs. Post-UF were made by Wilcoxon Signed Ranks Tests. Z: estimated statistics, r: effect size. *two-sided P < 0.05.
Values are presented as median (Q1, Q3). ROTEM: rotational thromboelastometry, UF: ultrafiltration, Pre-UF: immediately before applying UF, Post-UF: immediately after applying UF, Hct: hematocrit, EXTEM: extrinsically-activated test with tissue factor, FIBTEM: fibrin-based extrinsically activated test with tissue factor and the platelet inhibitor cytochalasin D, PLTEM: calculated value for estimating platelet contribution (PLTEM = EXTEM – FIBTEM) CT-EXTEM: clotting time of EXTEM, CFT-EXTEM: clot formation time of EXTEM, MCF-EXTEM: maximum clot firmness of EXTEM, A5-FIBTEM and MCF-FIBTEM: clot amplitude at 5 min after clot initiation and maximum clot firmness in FIBTEM, MCF-PLTEM: calculated value for estimating platelet contribution (MCF-PLTEM = MCF-EXTEM – MCF-FIBTEM), LI-30 EXTEM: lysis index at 30 min of EXTEM, ANOVA: Analysis of variance, and Nonparametric RM ANOVA with one repeated and one between factors. *two-side P value < 0.05.